New Zealand markets closed

Palisade Bio, Inc. (PALI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.76-0.18 (-2.65%)
As of 02:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 5.94M
Enterprise value -6.12M
Trailing P/E 0.15
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.73
Price/book (mrq)0.53
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.57

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-70.90%
S&P500 52-week change 326.43%
52-week high 336.60
52-week low 33.82
50-day moving average 35.89
200-day moving average 39.16

Share statistics

Avg vol (3-month) 31.14M
Avg vol (10-day) 31.37M
Shares outstanding 5851.4k
Implied shares outstanding 6851.4k
Float 8835.85k
% held by insiders 11.83%
% held by institutions 115.44%
Shares short (15 Apr 2024) 434.52k
Short ratio (15 Apr 2024) 40.5
Short % of float (15 Apr 2024) 44.75%
Short % of shares outstanding (15 Apr 2024) 44.05%
Shares short (prior month 15 Mar 2024) 43.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Jul 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 308 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,138.00%

Management effectiveness

Return on assets (ttm)-53.85%
Return on equity (ttm)-103.40%

Income statement

Revenue (ttm)250k
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.84M
Net income avi to common (ttm)-12.32M
Diluted EPS (ttm)-27.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.43M
Total cash per share (mrq)14.6
Total debt (mrq)369k
Total debt/equity (mrq)3.26%
Current ratio (mrq)5.15
Book value per share (mrq)18.30

Cash flow statement

Operating cash flow (ttm)-11.13M
Levered free cash flow (ttm)-6.47M